title: Current usefulness of Credé's method of preventing neonatal ophthalmia.
abstract: The conjunctiva's bacterial profile at birth and 1 week after Credé's gonoccocal ophthalmic prophylaxis was evaluated over a 3-month period using culture and direct immunofluorescence. Thirty-four neonates received 10% silver vitellinate and 42 sterile saline. Chlamydia trachomatis was recovered in 7/34 and 9/42 neonates receiving silver vitellinate and saline at birth and in 8/34 and 12/42 after 1 week, respectively. Neisseria gonorrhoeae was not identified. Credé's may not be the ideal prophylactic method in areas with a low prevalence of N. gonorrhoeae.
authors.affiliation: Federal University of Sergipe, Aracaju, Brazil.
authors.forename: Lusa Reis
authors.initials: LR
authors.lastname: Silva
authors.forename: Ricardo Queiroz
authors.initials: RQ
authors.lastname: Gurgel
authors.forename: Dorothy Ribeiro Resende
authors.initials: DR
authors.lastname: Lima
authors.forename: Luis E
authors.initials: LE
authors.lastname: Cuevas
mesh_terms: D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D003228:Conjunctiva / Q000382:microbiology; D003235:Conjunctivitis, Inclusion / Q000517:prevention & control; D009877:Endophthalmitis / Q000382:microbiology / Q000517:prevention & control*; D015818:Eye Infections, Bacterial / Q000382:microbiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D009883:Ophthalmic Solutions; D012836:Silver Proteins / Q000627:therapeutic use*
chemical_list: D000891:Anti-Infective Agents, Local; D009883:Ophthalmic Solutions; D012836:Silver Proteins; C000227:mild silver protein